phase 3 retatrutide Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can Diabetes Dialogue: Retatrutide Reduces Body

Cerebrospinal fluid

Prophylactic use of carnitine in such situations has been shown to reduce the endothelial damage caused by lipopolysaccharide (LPS) and TNF-

We've had patients come in with lab results that made no sense, traced back to a gray-market vial

Safety Considerations: GLP-1 Medications and Alcohol Use Understanding the safety profile of GLP-1 receptor agonists in the context of alcohol consumption is essential for both patients and healthcare professionals

Laugero KD, Stonehouse AH, Guss S, Landry J, Vu C, Parkes DG: Exenatide improves hypertension in a rat model of the metabolic syndrome

Sanyal Hepatology .2026;[Epub] CrossRef MASHRelated Liver Cancer Estimates Need AetiologySpecific Validation in the AsiaPacific Region Haoyang Hu Liver International .2026;[Epub] CrossRef Liver fibrosis in metabolic dysfunction-associated steatotic liver disease: epidemiology, risk stratification and therapeutics Fuliang Li, Hongmei Li, Dulguun Juramt, Kai Kou, Frank Tacke, Lanlan Chen BMJ Open Gastroenterology .2026